» Articles » PMID: 37929013

Cyclophotocoagulation in Neovascular Glaucoma with Near-Total Synechial Angle Closure

Overview
Publisher Wiley
Specialty Ophthalmology
Date 2023 Nov 6
PMID 37929013
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe a single surgeon's experience utilizing prompt primary slow-burn transscleral cyclophotocoagulation (CPC) with prior or concurrent anti-VEGF and subsequent aqueous shunt as needed in NVG eyes with near-total synechial angle closure at presentation.

Methods: Retrospective chart review of all NVG patients with uncontrolled IOP, active anterior segment NV, near-total synechial angle closure, and no contraindications to prompt anti-VEGF who received CPC within 3 days of presentation with at least 6 months of follow-up.

Results: Eight patients with mean age 60.6 years were included. Underlying etiologies were CRVO ( = 3), PDR ( = 2), CRAO ( = 1), BRVO ( = 1), and chronic RD ( = 1). All eyes underwent CPC with intravitreal anti-VEGF within 3 days of presentation. Five patients did not require subsequent aqueous shunts through a mean follow-up of 15 months; most recent visual acuities ranged from 20/40 to LP, and IOPs ranged from 5 to 11 mmHg on 0 to 3 IOP-lowering medications. Three patients who required subsequent tubes had complete regression of active anterior segment NV at the time of surgery. Most recent visual acuities ranged from 20/100 to 20/125, and IOPs ranged from 8 to 14 mmHg on 0 meds at a mean follow-up of 10 months. No eyes developed uncontrolled inflammation, sympathetic ophthalmia, or phthisis.

Conclusion: Prompt primary slow-burn CPC with prior or concurrent anti-VEGF may be an effective strategy to immediately lower IOP in acute NVG eyes with active anterior segment NV and near-total synechial angle closure. If IOP becomes uncontrolled later, an aqueous shunt can be implanted in a controlled setting after active anterior segment NV has regressed.

References
1.
Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F . Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008; 115(9):1571-80, 1580.e1-3. DOI: 10.1016/j.ophtha.2008.02.026. View

2.
Baez K, Ulbig M, McHugh D, Holz F, Spaeth G . Long-term results of ab externo neodymium:YAG cyclophotocoagulation. Ger J Ophthalmol. 1994; 3(6):395-9. View

3.
Godinho G, Barbosa-Breda J, Oliveira-Ferreira C, Madeira C, Melo A, Falcao-Reis F . Anterior Chamber Versus Ciliary Sulcus Ahmed Glaucoma Valve Tube Placement: Longitudinal Evaluation of Corneal Endothelial Cell Profiles. J Glaucoma. 2021; 30(2):170-174. DOI: 10.1097/IJG.0000000000001700. View

4.
Duerr E, Sayed M, Moster S, Holley T, Peiyao J, Vanner E . Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques. Ophthalmol Glaucoma. 2020; 1(2):115-122. PMC: 7337205. DOI: 10.1016/j.ogla.2018.08.007. View

5.
Tsai J, Feuer W, Parrish 2nd R, Grajewski A . 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 1995; 102(6):887-92; discussion 892-3. DOI: 10.1016/s0161-6420(95)30938-4. View